DSD-C265

46,XX DSD — androgen excess (androgen-secreting adrenocortical adenoma) · 46,XX · DSD-C265

DSD-C265 · 46,XX DSD — androgen excess (androgen-secreting adrenocortical adenoma) · 2022

Karyotype 46,XX

Functional (virilizing) adrenocortical adenoma causing clitoromegaly

Images · 1

Case fields and evidence

Category

46,XX DSD — androgen excess (androgen-secreting adrenocortical adenoma)

Age

9 months (female infant, firstborn, non-consanguineous)

Sex

Female

Karyotype

46,XX

Diagnosis

Functional (virilizing) adrenocortical adenoma causing clitoromegaly

Follow-up

6-month follow-up: asymptomatic, DHEA normal, no further increase in clitoromegaly

General phenotype

Female phenotype with virilization: clitoromegaly, abdominal mass

Imaging

Prenatal US left suprarenal mass; postnatal CECT 7.5×7.3×8.7 cm heterogeneously enhancing left adrenal mass displacing spleen/pancreas/kidney/IVC; MIBG no uptake; US-guided biopsy: adrenocortical neoplasm, Synaptophysin/Chromogranin/NSE/Vimentin/Inhibin positive, Ki-67 10%

Laboratory findings

DHEA markedly elevated (>1000 mcg/dl); cortisol, 17-OHP, AFP, β-hCG normal; urine VMA negative; epinephrine/metabolites negative

Management

Open left adrenalectomy; perioperative steroid replacement for 3 days; discharged day 4

Pathology

Resected left adrenal mass, Modified Weiss score 2/7 — adrenocortical adenoma (ACA)

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Genetics

See source

Cite this resource

DSD Research Library | 46,XX DSD — androgen excess (androgen-secreting adrenocortical adenoma) · 46,XX · DSD-C265 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C265?version=v1.4.0